Vaginal chitosan tablets with clotrimazole-design and evaluation of mucoadhesive properties using porcine vaginal mucosa, mucin and gelatine

Chemical and Pharmaceutical Bulletin

Volumn 62, Issue 2, 2014, Pages 160-167

  Szymanska, Emilia ^a   Winnicka, Katarzyna ^a   Amelian, Aleksandra ^a   Cwalina, Urszula ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Chitosan; Clotrimazole; Mucoadhesion; Mucoadhesive tablet; Texture analyser; Vaginal delivery

Indexed keywords

ADHESIVENESS; ADMINISTRATION, INTRAVAGINAL; ANIMALS; ANTIFUNGAL AGENTS; BIOCOMPATIBLE MATERIALS; CHITOSAN; CLOTRIMAZOLE; FEMALE; GELATIN; HARDNESS; MUCINS; MUCOUS MEMBRANE; SWINE; VAGINA; VAGINAL CREAMS, FOAMS, AND JELLIES;

EID: 84894229615     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.c13-00689     Document Type: Article

References (33)

1. Ferrer J., Int. J. Gynaecol. Obstet., 71 (Suppl. 1), S21-S27 (2000).
2. Lanchares J. L., Hernandez M. L., Int. J. Gynaecol. Obstet., 71 (Suppl. 1), S29-S35 (2000).
3. Chien Y. W., Lee C. H., "Encyclopedia of Pharmaceutical Technology," 3rd ed. Vol. 2, Chap. Drug Delivery: Vaginal Route, ed. by Swarbrick J., Informa Healthcare, New York, 2007, pp. 1139-1361.
4. "DrugBank Database (Internet).": http//www.drugbank.ca/drugs/ DB00257, cited 24 May, 2013.
5. Perioli L., Ambrogi V., Pagano C., Scuota S., Rossi C., Int. J. Pharm., 377, 120-127 (2009).
6. Woolfson A. D., Umrethia M. L., Kett V. L., Malcolm R. K., Int. J. Pharm., 388, 136-143 (2010).
7. Perioli L., Ambrogi V., Pagano C., Massetti E., Rossi C., Colloids Surf. B Biointerfaces, 84, 413-420 (2011).
8. Kean T., Thanou M., Adv. Drug Deliv. Rev., 62, 3-11 (2010).
9. Dash M., Chiellini F., Ottenbrite R. M., Chiellini E., Prog. Polym. Sci., 36, 981-1014 (2011).
10. Muzzarelli R. A., Cell. Mol. Life Sci., 53, 131-140 (1997).
11. Meng J., Sturgis T. F., Youan B. C., Eur. J. Pharm. Sci., 44, 57-67 (2011).
12. Bonferoni M. C., Sandri G., Rossi S., Ferrari F., Gibin S., Caramella C., Eur. J. Pharm. Sci., 33, 166-176 (2008).
13. Knapczyk J., Macura A. B., Pawlik B., Int. J. Pharm., 80, 33-38 (1992).
14. Knapczyk J., Int. J. Pharm., 88, 9-14 (1992).
15. Szymańska E., Winnicka K., Acta Pol. Pharm., 69, 509-513 (2012).
16. Stasiak P., Placzek M., Lepek P., Sznitowska M., J. Dispers. Sci. Technol., 32, 1780-1785 (2011).
17. Baloglu E., Ay Senyigit Z., Karavana S. Y, Vetter A., Metin D. Y., Hilmioglu Polat S., Guneri T., Bernkop-Schnurch A., Chem. Pharm. Bull., 59, 952-958 (2011).
18. Pliszczak D., Bordes C., Bourgeois S., Marote P., Zahouani H., Tupin S., Mattei C. P., Lanteri P., Colloids Surf. B Biointerfaces, 92, 168-174 (2012).
19. Squier C. A., Mantz M. J., Schlievert P. M., Davis C. C., J. Pharm. Sci., 97, 9-21 (2008).
20. "European Pharmacopeia," 6th ed., Vol. 1, Chap. 2.9, Council of Europe, Strasburg, 2007.
21. Winnicka K., Sosnowska K., Wieczorek P., Sacha P. T., Tryniszewska E., Biol. Pharm. Bull., 34, 1129-1133 (2011).
22. Singh S., Jain S., Muthu M. S., Tilak R., Curr. Drug Deliv., 5, 133-141 (2008).
23. Szymańska E., Winnicka K., Trop. J. Pharm. Res., 12, 39-44 (2013).
24. Siepmann J., Peppas N. A., Adv. Drug Deliv. Rev., 48, 139-157 (2001).
25. Costa P., Sousa Lobo J. M., Eur. J. Pharm. Sci., 13, 123-133 (2001).
26. Nakamura F., Ohta R., Machida Y., Nagai T., Int. J. Pharm., 134, 173-181 (1996).
27. Chatterjee A., Bhowmik B. B., Kumar L., J. Pharm. Res., 2, 698-700 (2009).
28. Rege P. R., Shukla D. J., Block L. H., Int. J. Pharm., 181, 49-60 (1999).
29. Wan L. S. C., Heng P. W. S., Wong L. F., Drug Dev. Ind. Pharm., 19, 1201-1210 (1993).
30. Carcía-González N., Kellaway I. W., Blanco-Fuente H., Anguiano-Igea S., Delgado-Charro B., Otero-Espinar F. J., Blanco-Méndez J., Int. J. Pharm., 100, 65-70 (1993).
31. Savaşer A., Özkan Y., Işimer A., Farmaco, 60, 171-177 (2005).
32. D'Cruz O. J., Erbeck D., Uckun F. M., Toxicol. Pathol., 33, 465-476 (2005).
33. Deacon M. P., McGurk S., Roberts C. J., Williams P. M., Tendler S. J., Davies M. C., Davis S. S., Harding S. E., Biochem. J., 348, 557-563 (2000).